← Leaderboards
Andrew R Haas
University Of Pennsylvania
$3,721,334
Attributed
$3,721,334
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $749.4K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,721,334 · 1
By mechanism
P01$3,721,334 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Steven Mark Albelda$22,046,338
- Daniel Sterman$5,215,085
- Edmund K. Moon$2,330,962
- Ellen Pure'$9,984,943
- Wei-Ting Hwang$3,071,182
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesAntigen TargetingAntigensAreaBaseB-LymphocytesCancer EtiologyAnti-Pd1 AntibodiesCd19 AntigensCell KillingChemotherapy-Oncologic ProcedureChimeric Antigen ReceptorClinical ResearchClinical TrialsCyclophosphamideDesignCancer PatientEngineeringEpitope SpreadingFibroblast-Activating FactorFibroblastsFunctional DisorderFutureGenetic Engineering
Grant awards (5)
Project 1 - Clinical Trial$734,412
P01 · FY2022 · CA · contact PI
Project 1 - Clinical Trial$749,398
P01 · FY2021 · CA · contact PI
Project 1 - Clinical Trial$749,398
P01 · FY2020 · CA · contact PI
Project 1 - Clinical Trial$738,729
P01 · FY2019 · CA · contact PI
Project 1 - Clinical Trial$749,397
P01 · FY2018 · CA · contact PI